Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age
Clinical trial NCT01934127 · COMPLETED
Trial details
- NCT number
- NCT01934127
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-26
- Primary completion
- 2013-11-01
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.